Update on community-acquired pneumonia. New pathogens and new concepts in treatment.
Identifieur interne : 001266 ( Ncbi/Checkpoint ); précédent : 001265; suivant : 001267Update on community-acquired pneumonia. New pathogens and new concepts in treatment.
Auteurs : Lionel A. Mandell [Canada]Source :
- Postgraduate medicine [ 0032-5481 ] ; 2005.
Descripteurs français
- KwdFr :
- Anti-infectieux (administration et posologie), Association de médicaments, Calendrier d'administration des médicaments, Humains, Infections communautaires (microbiologie), Infections communautaires (traitement médicamenteux), Metapneumovirus, Pneumopathie infectieuse (microbiologie), Pneumopathie infectieuse (traitement médicamenteux), Résistance à la méticilline, Staphylococcus aureus, Virus du SRAS.
- MESH :
- administration et posologie : Anti-infectieux.
- microbiologie : Infections communautaires, Pneumopathie infectieuse.
- traitement médicamenteux : Infections communautaires, Pneumopathie infectieuse.
- Association de médicaments, Calendrier d'administration des médicaments, Humains, Metapneumovirus, Résistance à la méticilline, Staphylococcus aureus, Virus du SRAS.
English descriptors
- KwdEn :
- Anti-Infective Agents (administration & dosage), Community-Acquired Infections (drug therapy), Community-Acquired Infections (microbiology), Drug Administration Schedule, Drug Therapy, Combination, Humans, Metapneumovirus, Methicillin Resistance, Pneumonia (drug therapy), Pneumonia (microbiology), SARS Virus, Staphylococcus aureus.
- MESH :
- chemical , administration & dosage : Anti-Infective Agents.
- drug therapy : Community-Acquired Infections, Pneumonia.
- microbiology : Community-Acquired Infections, Pneumonia.
- Drug Administration Schedule, Drug Therapy, Combination, Humans, Metapneumovirus, Methicillin Resistance, SARS Virus, Staphylococcus aureus.
Abstract
Recent years have witnessed the emergence of new pathogens linked to community-acquired pneumonia (CAP) along with new antibiotics designed to combat them. In this article, Dr Mandell presents an expert's view on these developments in the context of treatment guidelines for CAP. He also explores monotherapy versus combination therapy, the efficacy of rapid initiation of treatment, and short-course therapy as a hedge against antimicrobial resistance.
DOI: 10.3810/pgm.2005.10.1699
PubMed: 16296262
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002445
- to stream PubMed, to step Curation: 002445
- to stream PubMed, to step Checkpoint: 002407
- to stream Ncbi, to step Merge: 001266
- to stream Ncbi, to step Curation: 001266
Links to Exploration step
pubmed:16296262Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Update on community-acquired pneumonia. New pathogens and new concepts in treatment.</title><author><name sortKey="Mandell, Lionel A" sort="Mandell, Lionel A" uniqKey="Mandell L" first="Lionel A" last="Mandell">Lionel A. Mandell</name><affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada. lmandell@mcmaster.ca</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Infectious Diseases, McMaster University Faculty of Health Sciences, Hamilton, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16296262</idno><idno type="pmid">16296262</idno><idno type="doi">10.3810/pgm.2005.10.1699</idno><idno type="wicri:Area/PubMed/Corpus">002445</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002445</idno><idno type="wicri:Area/PubMed/Curation">002445</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002445</idno><idno type="wicri:Area/PubMed/Checkpoint">002407</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002407</idno><idno type="wicri:Area/Ncbi/Merge">001266</idno><idno type="wicri:Area/Ncbi/Curation">001266</idno><idno type="wicri:Area/Ncbi/Checkpoint">001266</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Update on community-acquired pneumonia. New pathogens and new concepts in treatment.</title><author><name sortKey="Mandell, Lionel A" sort="Mandell, Lionel A" uniqKey="Mandell L" first="Lionel A" last="Mandell">Lionel A. Mandell</name><affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada. lmandell@mcmaster.ca</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Infectious Diseases, McMaster University Faculty of Health Sciences, Hamilton, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></analytic><series><title level="j">Postgraduate medicine</title><idno type="ISSN">0032-5481</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Infective Agents (administration & dosage)</term><term>Community-Acquired Infections (drug therapy)</term><term>Community-Acquired Infections (microbiology)</term><term>Drug Administration Schedule</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Metapneumovirus</term><term>Methicillin Resistance</term><term>Pneumonia (drug therapy)</term><term>Pneumonia (microbiology)</term><term>SARS Virus</term><term>Staphylococcus aureus</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anti-infectieux (administration et posologie)</term><term>Association de médicaments</term><term>Calendrier d'administration des médicaments</term><term>Humains</term><term>Infections communautaires (microbiologie)</term><term>Infections communautaires (traitement médicamenteux)</term><term>Metapneumovirus</term><term>Pneumopathie infectieuse (microbiologie)</term><term>Pneumopathie infectieuse (traitement médicamenteux)</term><term>Résistance à la méticilline</term><term>Staphylococcus aureus</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Infective Agents</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anti-infectieux</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Community-Acquired Infections</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Infections communautaires</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Community-Acquired Infections</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections communautaires</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Administration Schedule</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Metapneumovirus</term><term>Methicillin Resistance</term><term>SARS Virus</term><term>Staphylococcus aureus</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term><term>Calendrier d'administration des médicaments</term><term>Humains</term><term>Metapneumovirus</term><term>Résistance à la méticilline</term><term>Staphylococcus aureus</term><term>Virus du SRAS</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Recent years have witnessed the emergence of new pathogens linked to community-acquired pneumonia (CAP) along with new antibiotics designed to combat them. In this article, Dr Mandell presents an expert's view on these developments in the context of treatment guidelines for CAP. He also explores monotherapy versus combination therapy, the efficacy of rapid initiation of treatment, and short-course therapy as a hedge against antimicrobial resistance.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Mandell, Lionel A" sort="Mandell, Lionel A" uniqKey="Mandell L" first="Lionel A" last="Mandell">Lionel A. Mandell</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001266 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001266 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:16296262
|texte= Update on community-acquired pneumonia. New pathogens and new concepts in treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:16296262" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |